Stay updated on UC-961 in Relapsed CLL Clinical Trial
Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update does not modify study data or page content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; the old government funding/status notice was removed, and the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedDifference0.4%

- Check48 days agoChange DetectedAdded a new Study Protocol and Statistical Analysis Plan PDF (2015-06-25, 1.91MB) under Study Documents. Expanded the page with additional metadata including MeSH terms and keywords, and updated verification dates.SummaryDifference59%

- Check62 days agoChange DetectedMinor site update: addition of Revision: v3.3.4 and deletion of Revision: v3.3.3, with no changes to study content or page layout; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new 'Locations' section with a California entry to the study details and updated the revision to v3.3.3. Removed the previous California Locations block and the HHS Vulnerability Disclosure footer, with the change history adjusted from v3.3.2.SummaryDifference0.2%

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.